Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07299071 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

Study acronym: IA-COLO 2
StatusRecruiting
PhaseNot applicable
Started2026-03-13
View on ClinicalTrials.gov ↗

Amendment history

2026-03-13
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2026-03→confirmed 2026-03-13
Study sitesdetails revised at 13 of 13 sites
2025-12-23
Study Identification, Study Status v1
Study title-43 characters
Randomized Controlled Trial Evaluating the Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
2025-12-09
Original filing
The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.
Trial Details
NCT Number NCT07299071
Lead Sponsor University Hospital, Bordeaux
Conditions Colonoscopy, Colorectal Neoplasms, Intestinal Polyps
Enrollment 592 participants
Start Date 2026-03-13
Primary Completion 2031-03 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2026-09-24